Aceruloplasminemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:48818OMIM:604290E83.1
Who is this for?
Show terms as
1FDA treatments1Active trials20Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aceruloplasminemia is a rare inherited condition where the body cannot make a working form of a protein called ceruloplasmin. Ceruloplasmin normally helps move iron out of cells, especially in the brain, liver, and pancreas. Without it, iron builds up slowly in these organs over many years, causing serious damage. The disease is also sometimes called 'hereditary ceruloplasmin deficiency.' The iron buildup causes a combination of problems that are unusual to see together: diabetes (from damage to the pancreas), anemia (low red blood cells, from problems in the liver), and neurological symptoms (from iron damage to the brain). Brain symptoms often include movement problems like tremors or difficulty walking, as well as memory and thinking difficulties. Eye problems, including a condition called retinal degeneration, can also occur. Most people do not notice symptoms until adulthood, often in their 40s or 50s, because the iron builds up slowly over decades. There is no cure, but treatments aimed at reducing iron levels — such as iron-chelating medications — can help slow the disease. Managing diabetes and anemia is also an important part of care. Early diagnosis is key to preventing the worst outcomes.

Also known as:

Key symptoms:

Diabetes (high blood sugar)Anemia (low red blood cells causing tiredness and paleness)Involuntary shaking or tremorsDifficulty walking or coordinating movementsMemory problems or confusionSlow or slurred speechVision loss or retinal damageAbnormal eye movementsDifficulty swallowingPsychiatric symptoms such as depression or behavioral changesIron buildup visible on brain MRI scans

Clinical phenotype terms (41)— hover any for plain English
Hypochromic microcytic anemiaHP:0004840Refractory anemiaHP:0005505AceruloplasminemiaHP:0025498Retinal degenerationHP:0000546Macular degenerationHP:0000608Decreased circulating ceruloplasmin concentrationHP:0010837Decreased circulating copper concentrationHP:0011967Elevated hepatic iron concentrationHP:0012465
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2012TIRCON International NBIA Registry

LMU Klinikum

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

ATryn

recombinant human antithrombin· GTC Biotherapeutics, Inc.Orphan Drug

Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
TIRCON International NBIA Registry
Actively Recruiting
PI: Thomas Klopstock, Prof. Dr. (LMU Klinikum, Friedrich-Baur-Institute) · Sites: Ottawa; Prague +7 more

Specialists

20 foundView all specialists →
TW
Tong Wu
Specialist
1 Aceruloplasminemia publication
YD
Yi Dong
Specialist
1 Aceruloplasminemia publication
AZ
Alan Zanardi
Specialist
3 Aceruloplasminemia publications
MA
Massimo Alessio
Specialist
3 Aceruloplasminemia publications
WX
Wan-Qing Xu
Specialist
1 Aceruloplasminemia publication
WN
Wang Ni
Specialist
1 Aceruloplasminemia publication
RW
Rou-Min Wang
Specialist
1 Aceruloplasminemia publication
ZW
Zhi-Ying Wu
Specialist
1 Aceruloplasminemia publication
TD
Thomas Klopstock, Prof. Dr.
Specialist
PI on 3 active trials
AC
Andrea Caricasole
Specialist
3 Aceruloplasminemia publications
SB
Sara Belloli
Specialist
2 Aceruloplasminemia publications
CM
Cristina Monterisi
Specialist
2 Aceruloplasminemia publications
PR
Paolo Rainone
Specialist
2 Aceruloplasminemia publications
AC
Angela Coliva
Specialist
2 Aceruloplasminemia publications
AC
Antonio Conti
Specialist
2 Aceruloplasminemia publications
RM
Rosa Maria Moresco
Specialist
2 Aceruloplasminemia publications
EG
Enrica Gilberti
Specialist
2 Aceruloplasminemia publications
BF
Barbara Ferrini
Specialist
2 Aceruloplasminemia publications
SR
Sara Raia
Specialist
2 Aceruloplasminemia publications
WC
Wanjin Chen
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

Lariam

Hoffmann-La Roche, Inc.

Lariam Patient Support (Genentech Access Solutions)

Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Aceruloplasminemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open AceruloplasminemiaForum →

No community posts yet. Be the first to share your experience with Aceruloplasminemia.

Start the conversation →

Latest news about Aceruloplasminemia

Disease timeline:

New recruiting trial: TIRCON International NBIA Registry

A new clinical trial is recruiting patients for Aceruloplasminemia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my iron buildup at, and which organs are most affected right now?,Should I start iron chelation therapy, and which medication would be best for me?,How often should I have MRI scans and blood tests to monitor my condition?,Are any of my family members at risk, and should they be tested?,Are there any clinical trials I might be eligible for?,What symptoms should prompt me to seek emergency care?,What specialists should be part of my care team, and how often should I see each one?

Common questions about Aceruloplasminemia

What is Aceruloplasminemia?

Aceruloplasminemia is a rare inherited condition where the body cannot make a working form of a protein called ceruloplasmin. Ceruloplasmin normally helps move iron out of cells, especially in the brain, liver, and pancreas. Without it, iron builds up slowly in these organs over many years, causing serious damage. The disease is also sometimes called 'hereditary ceruloplasmin deficiency.' The iron buildup causes a combination of problems that are unusual to see together: diabetes (from damage to the pancreas), anemia (low red blood cells, from problems in the liver), and neurological symptoms

How is Aceruloplasminemia inherited?

Aceruloplasminemia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aceruloplasminemia typically begin?

Typical onset of Aceruloplasminemia is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Aceruloplasminemia?

Yes — 1 recruiting clinical trial is currently listed for Aceruloplasminemia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Aceruloplasminemia?

20 specialists and care centers treating Aceruloplasminemia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Aceruloplasminemia?

2 patient support programs are currently tracked on UniteRare for Aceruloplasminemia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.